Continuous renal replacement therapy in patients with systemic sepsis (Review article)

Egyptian Journal of Anaesthesia

Volumn 25, Issue 4, 2009, Pages 463-471

  Moemen, Mohamed Ezzat ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDOSIS; ARTERIAL PRESSURE; ARTIFICIAL KIDNEY; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS HEMODIALYSIS; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; DIALYSATE; HEMODYNAMICS; HUMAN; PERITONEAL DIALYSIS; REVIEW; SEPSIS; SLOW CONTINUOUS ULTRAFILTRATION; THERAPY EFFECT; UREMIA;

EID: 78649437154     PISSN: 11101849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Linde-Zwirble WT, Angus DC: Severe sepsis epidemiology: Sampling, selection, and society. Crit Care 2004; 8: 222-6.
2. Dombrovskiy VY, Martin AA, Sunderram J, et al: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007; 35: 1414-15.
3. Knaus WA, Draper EA, Wagner DP, et al: Prognosis in acute organ-system failure. Ann Surg 2002; 685: 1985.
4. Deitch EA: Multiple organ failure: Pathophysiology and potential future therapy. Ann Surg 1992 ; 216 :117.
5. Dellinger RP, Carlet JM, Masur H, et al.: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 8 :227.
6. Bellomo R, Ronco C: Continuous hemofiltration in the intensive care unit. Crit Care 2000; 4: 339-45.
7. Bellomo R, Ronco C: Acute renal failure, management. In: Oxford Textbook of Critical Care. Oxford University Press; 1999: 419-22.
8. Schortgen F, Soubrier N, Delclaux C, et al: Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practical guidelines. Am J. Respir Crit Care Med 2000, 16: 197-202. (Pubitemid 30469820)
9. Schiff H, Lang S, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 306-10.
10. Leunissen KML, Hoornte SJ, Fiers HA, et al: Acetate versus bicarbonate hemodialysis in critically-ill patients. Nephron 1986; 42: 146-51.
11. Stevens PE, Davies SP. Renal replacement therapy - new developments. In: Recent advances in critical care medicine, 4 Editors: Evans TW, Hinds CJ, Churchill Livingstone, 1996, chapter 11, 231-59.
12. Bellomo R, Parkin G, Love J, et al : A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients. Am J Kidney Dis 1993, 21: 400-4. (Pubitemid 23132905)
13. Ronco C, Bellomo R: Nomenclature for continuous renal replacement therapies. Critical Care Nephrology 1998; 1176: 1169.
14. Kellum JA, Johnson JP, Kramer, et al. Diffusive versus Convective therapy : Effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 1998, 26: 1995-2000.
15. Geronemus R, Schneider N. Continuous arteriovenous hemodialysis: A new modality for the treatment of acute renal failure. Trans Am Soc Artif Intern Organs. 1984; 30: 610-12. (Pubitemid 15520050)
16. Hoffman JN, Hartl WH, Deppisch R. Hemofiltration in human sepsis : Evidence for elimination of immunomodulatory substances. Kidney Int 1995; 48 :1563.
17. Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: A prospective randomized trial. Lancet 2000, 356: 26-30. (Pubitemid 30416991)
18. Cole L, Bellomo R, Journois D, et al: High-volume haemofiltration in human septic shock. Intensive Care Med 2001, 27: 978-86.
19. Oudemans-Van Straaten HM, Bosman RJ, van der Spoel JI, et al: Outcome of critically ill patients treated with intermittent high-volume haemofiltration: A prospective cohort analysis. Intensive Care Med 1999, 25: 814-21.
20. Honore PM, Jamez J, Wauthier M, et al: Prospective evaluation of shortterm, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000, 28, 3587-81.
21. Ronco C, Bellomo R.: Continuous high flux dialysis: An efficient renal replacement. In : Yearbook of Intensive Care and Emergency Medicine. 1996: 690-6.
22. Canaud B, Mion C.: Extracorporeal treatment of acute renal failure: Methods, indications, quantified and personalized therapeutic approach. Adv Nephrol 1995; 24: 271-81.
23. Liano F, Junco E, Pascual J, et al: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. Kidney Int 1998; 53 (suppl. 66): S16-S24.
24. Bellomo R, Farmer M, Wright C, et al: Treatment of sepsis-associated severe acute renal failure with continuous hemodiafiltration: Clinical experience and comparison with conventional dialysis. Blood Purif 1995; 13: 246-54.
25. Silvester W, Bellomo R, Ronco C.: Continuous versus intermittent renal replacement therapy in the critically ill. Critical Care Nephrol 1998: 1225-38.
26. Lundberg JS, Perl TM, Wiblin T, et al: Septic shock, an analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med 1998; 26: 1020-4. (Pubitemid 28272851)
27. Rivers E, Nguyen B, Havstad S et al.: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77.
28. Rice TW, Bernard GR. Therapeutic interventions and targets for sepsis. Ann Rev Med 2005; 56 : 225.
29. Uchino S, Fealy N , Baldwin I. Predilution versus post-dilution during continuous venovenous hemofiltration: Impact on filter life and azotemic control. Nephron Clin Pract 2003; 94 : 94.
30. Groeneveld ABJ, Tacx AN, Bossink AWJ, et al.: Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection. Clin Immunol 2003; 106: 106-15.
31. Reinhart K, Menges T, Gardlund B, et al.: The afelimomab sepsis study group. Randomized, Placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES study. Crit Care Med 2001; 29: 765-9.
32. Harbarth S, Holeckova K, Froidevaux C, et al.: The Geneva sepsis network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396-402.
33. Luzzani A, Polati E, Dorizzi R, et al.: Comparison of procalcitonin and Creactive protein as markers of sepsis. Crit Care Med 2003; 31: 1737-41.
34. Martin C, Saux P, Mege JL, et al.: Prognostic values of serum cytokines in septic shock. Intensive Care Med 1994; 20: 272-7. (Pubitemid 24132367)
35. Pinsky MR, Vincent JL, Deviere J, et al.: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103: 565-75.
36. Aouifi A, Piriou V, Bastien O, et al.: Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 2000; 28: 3171-6.
37. Jens Ulrik Jensen; Lars Heslet; Tom Hartvig Jensen; et al: Procalcitonin increase in early identification of critically ill patients at high risk of mortality: Crit Care Med 2006; 34: 2596-602.
38. Taylor FB, Dahlback B, Chang AC, et al.: Role of free protein S and C4b binding protein in regulating the coagulant response to Escherichia coli. Blood 1995; 86: 2642-52.
39. Vincent J-L, Tielemans C: Continuous hemofiltration in severe sepsis: is it beneficial? J Crit Care 1995; 10: 27-32.
40. Silvester W: Mediator removal with continuous renal replacement therapy : complement and cyokines. Am J Kidney Dis 1997, 30: S38-S43.
41. Stein B, Pfenninger E, Grunert A, et al: Influence of blood volume in experimental endotoxic shock. Intensive Care Med 1990, 16: 494-499.
42. Grootendorst AF, van Bommel EF, van Leengoed LA, et al: Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 1993, 8: 161-9.
43. Bellomo R, Baldwin I, Cole L, et al : Prelimiary experience with high-volume hemofiltration in human septic shock. Kidney Int 1998; 53: S182-S185.
44. Lee PA, Matson JR, Pryor RW, et al: Continous arteriovenous hemofiltraton therapy for Staphylococcus aureus induced septicemia in immature swine. Crit Care Med 1993, 21: 914-24.
45. Von Andrian UH, Mackay CR: T-cell function and migration : Two sides of the same coin. N Engl J Med 2000, 343: 1020-34.
46. De Vriese AS, Colardyn FA, Philippe JJ, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999, 10: 846-53.
47. Winchester JF, Kellum JA, Ronco C, et al: Sorbents in acute renal failure and the systemic inflammatory response syndrome. Blood Purif 2003; 21: 79-84. (Pubitemid 36173353)
48. Honore PM, Matson JR.: Short-term high-volume hemofiltraiton in sepsis: perhaps the right way is to start with. Crit Care Med 2002; 30: 1673-4.
49. Bellomo, R, Farmer, M, Wright, et al: Treatment of sepsis-associated acute renal failure with continuous hemodiafiltraiton: Clinical experience and comparison with conventional dialysis. Blood Purif 1995, 13: 246-54.
50. Gotloib L., Shostak A., Fudin R., et al: Treatment of surgical and nonsurgical septic multi-organ failure with bicarbonate hemodialysis and sequential hemofiltration. Intensive Care Med 1995; 21: 104-11.
51. Bernard Page, Antoine Vieillard. Baron J, et al: Early venovenous haemodiafiltration for sepsis-related multiple organ failure. Critical Care 2005, 9: R755-R763.
52. Bouman L , Catherine SC, Oudemans-van Straaten, et al: Timing of renal replacement therapy in critically ill patients with acute kidney injury. Curr Opin Critical Care 2007 ; 13 : 656-61.
53. Piccinni P., Dan M., Barbacini S, et al: Early isovolemic hemofiltraiton in oliguric patients with septic shock: Intens Care Med 2006; 8 : 110-13.
54. Sayed MS, El-sherif A, Sherif H, et al: Role of early continuous venovenous hemofiltration in septic shock and multiple organ failure. Master Thesis in Critical Care Medicine, faculty of medicine, Cairo university; 2009 : 35-9.
55. Awady GA, Farag WA, Werner F. Effect of hemofiltration in elimination of immunomodulatory mediators in septic shock ,and effect on hemodynamics. MD Thesis in Crit Care Med. Cairo university, Egypt, 1998: 140-3.
56. Hazem AM, Ibrahim EE, Ebada E. Effect of CVVH on cardiovascular hemodynamics and removal of inflammatory meriators in critically-ill patients. EJIC 2007; 12 : 161-72.
57. Dodd NJ, Turney JH, Parsons V, et al. Continuous hemofiltration maintains fluid balance and reduces hemodialysis requirements in acute renal failure. Proc Eur Dial Transplant Assoc. 1982; 19: 329-33.
58. Leung AC, Simpson K, Gribben J, et al. Arteriovenous hemofiltration. Br Med J 1983 ; 287 : 1722.
59. Lameire N, Van Biesen W, Vanholder R.: Dialysing the patient with acute renal failure in the ICU: The emperor's clothes? Nephrol Dial Transplant 1999; 14: 2570-2573.